Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug. - Wikidata - wikimedia - TriplyDB

Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug.

Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug.

http://www.wikidata.org/entity/Q41913846

about

Comparison of spray freeze drying and the solvent evaporation method for preparing solid dispersions of baicalein with Pluronic F68 to improve dissolution and oral bioavailability.Combined application of mixture experimental design and artificial neural networks in the solid dispersion development.Dissolution enhancement of glibenclamide by solid dispersion: solvent evaporation versus a supercritical fluid-based solvent -antisolvent technique.Dissolution improvement of electrospun nanofiber-based solid dispersions for acetaminophen.Design and optimization of mefloquine hydrochloride microparticles for bitter taste masking.Preparation, Characterization and Pharmacodynamic Evaluation of Fused Dispersions of Simvastatin using PEO-PPO Block Copolymer.Design and optimization of artemether microparticles for bitter taste masking.Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation.Preparation and characterization of Simvastatin solid dispersion using skimmed milk.

P2860

Q34733861-8B5D40CF-5743-4909-A274-7A3FBED63CF3 Q40845484-CE4456F6-DCB1-4AC2-A452-DA6D86E8F4F7 Q41836027-DAC51A17-985F-4D01-B828-7034BF620C91 Q41968403-989626E4-BA04-4EC9-BE51-1A330A4DDE4F Q41989651-81EA9EE4-32C1-47F5-8805-EE0174415A5D Q42880736-C1071C8E-C0DF-415A-972D-4C22FBED78FD Q46185866-4AF33BED-2125-44F7-B33C-9D544BCF4D72 Q47102002-B1EE58C4-AFFB-416B-8FB7-A1F5316DD5B9 Q54695491-7A998B84-ED0A-40C5-BE2C-0B77BE9A68FC

P2860

Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug.

http://www.wikidata.org/entity/Q41913846

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Process optimization and chara ...... f a poorly water-soluble drug.

@en

type

label

Process optimization and chara ...... f a poorly water-soluble drug.

@en

prefLabel

Process optimization and chara ...... f a poorly water-soluble drug.

@en

P1433

Q41913846-ED477829-EF7D-45E0-B5CE-F119B8596FAD

P1476

Q41913846-AF2A163C-5589-4942-8A76-B88B268E79D0

P2093

Q41913846-2D52D27B-CD49-4CB4-86A4-D0267B55F1EC

Q41913846-697AA01A-0D92-4B0E-AC24-0551E251C83F

Q41913846-848CF287-E193-4BC3-AAEF-6019F46A9512

Q41913846-F6790000-8CD6-47A5-AB09-B0CC6D34CA28

P2860

Q41913846-0ABD41AE-8EBA-4B9D-AB03-41F461199BE4

Q41913846-419829DD-4A39-4FF8-B47D-413685DB6519

Q41913846-439DFC04-AC04-40DF-9F1D-F431D263412D

Q41913846-4891F397-1F47-4332-8B6C-07E6BAEC4AAA

Q41913846-4A95B482-5B9F-4410-B7A6-3BAC4F1E56A4

Q41913846-58B7CB01-DA39-4B17-BB88-E4B183B99048

Q41913846-58F3109A-7921-4229-8168-BCD442AD878D

Q41913846-6E18C6F6-F4E4-485F-B61A-026F494FFB3C

Q41913846-6E8B2AC9-F230-4FFB-8D00-D4813CF3D6A4

Q41913846-7C111B79-01C6-497B-A4DB-BA6BD62E288E

P2888

Q41913846-65CEDC28-80DE-40FE-B9B7-FB188E548CB6

P304

Q41913846-C3DD1651-8D3A-4236-9EFF-ABB3C43F585C

P31

Q41913846-A7C34D9D-0FF6-4C5F-80A8-5F7CE03EE77A

P356

Q41913846-38849F17-1DF3-4750-B7E7-CCE9AEE4F923

P407

Q41913846-F3B2671E-1B23-4EBE-BA8F-AE1381A1D3D2

P433

Q41913846-F34D8024-8757-445A-BBA0-5F5B82E1575C

P478

Q41913846-E559D475-C629-466E-974C-0D92C8329FC0

P577

Q41913846-81666A4A-858B-43F1-8566-AD3B85A82032

P5875

Q41913846-48873E56-7195-4874-AAB7-287EE675B37B

P6179

Q41913846-D689D765-9192-4EB1-A999-E0FD046CB8E8

P698

Q41913846-39A682BF-5487-4262-B8F6-5DED921CC232

P932

Q41913846-7D823F83-B1D1-4147-8F53-4BC6D6DCA989

P356

P1433

AAPS PharmSciTech

P1476

Process optimization and chara ...... f a poorly water-soluble drug.

@en

P2093

Avani F Amin

http://www.w3.org/2001/XMLSchema#string

Jolly R Parikh

http://www.w3.org/2001/XMLSchema#string

Rajesh H Parikh

http://www.w3.org/2001/XMLSchema#string

Tejal J Shah

http://www.w3.org/2001/XMLSchema#string

P2860

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.

Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs.

Improving drug solubility for oral delivery using solid dispersions.

Risk of cardiovascular events associated with selective COX-2 inhibitors.

Polymeric micelles for delivery of poorly water-soluble compounds.

Pharmaceutical applications of solid dispersion systems.

Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability.

Preparation and characterisation of ibuprofen-poloxamer 188 granules obtained by melt granulation.

Multi-unit controlled release systems of nifedipine and nifedipine:pluronic F-68 solid dispersions: characterization of release mechanisms.

P2888

P304

Article 29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/PT0802029

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2007-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6216186

http://www.w3.org/2001/XMLSchema#string

P6179

1016779446

http://www.w3.org/2001/XMLSchema#string

P698

17622107

http://www.w3.org/2001/XMLSchema#string

P932

2750369

http://www.w3.org/2001/XMLSchema#string